News

Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI‑driven ECG signal‑processing solutions MaxYield™ and CardioYield™ across wearables and ...
New board-level committee will steer regulatory strategy, IP development, and product innovation across AIML's AI-driven health-tech portfolio TORONTO, ON / ACCESS Newswire / May 22, 2025 / AI/ML Inno ...
TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a developer of AI-based signal processing technologies for ...
VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Michael Diamond to its ...
VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Michael Diamond to its ...
AIML's shares trade on the Canadian Securities Exchange (CSE: AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB). On behalf of the Board of Directors:Paul Duffy ...